The development of a novel, multilingual IBD knowledge questionnaire for Asian patients with inflammatory bowel disease.


Journal

BMC gastroenterology
ISSN: 1471-230X
Titre abrégé: BMC Gastroenterol
Pays: England
ID NLM: 100968547

Informations de publication

Date de publication:
25 May 2023
Historique:
received: 20 01 2023
accepted: 13 05 2023
medline: 29 5 2023
pubmed: 26 5 2023
entrez: 25 5 2023
Statut: epublish

Résumé

Inflammatory bowel disease is an uncommon disease in developing nations whereby patient's knowledge on the disease may be limited. The CCKNOW questionnaire, a widely known questionnaire to assess patient's knowledge on the disease, may be too complex to comprehend for patients in developing countries. The aim of this study is to develop a new tool known as AIBDKQ questionnaire to evaluate the local inflammatory bowel disease patient's knowledge. This was a prospective study carried out in four phases. In phase 1, three gastroenterologists with expertise in IBD generated a total of 21 questions related to the general knowledge of the disease in the English language. Phase 2 involved content and face validity whereby the questions were further validated by other gastroenterologists. In phase 3, the validated questions were translated into three languages namely Malay, Mandarin and Tamil which are commonly used in Malaysia. In phase 4 (statistical validity), administration of the questionnaires to patients and hospital staff were conducted to assess the construct validity, discriminative ability, predictive validity and reliability of the questionnaires. A total of 21 questions were generated initially. Further evaluation indicated that 20 items had adequate kappa and content validity index for relevance (CVI: 0.714 to 1, Kapp: 0.645 to 1) and clarity (CVI: 0.714 to 1, Kapp: 0.645 to 1). The questionnaires in four languages were administered to 213 patients to assess the construct validity. Six items were removed (three for low communality, one for small loading factors, two for cross loading), resulting in 16 final questions. Assessment with 34 hospital staff involving nurses, doctors and clerks showed significant differences in knowledge between the groups (F = 14.007, p < 0.001) and were able to discriminate doctors from nurses and clerks. Another group of 18 hospital staff administered with AIBDKQ and CCKNOW questionnaires showed a Pearson's correlation coefficient of 0.8 indicating strong correlation and concurrent predictive validity between the two questionnaires. Final assessment with 38 patients for reliability assessment revealed high intraclass correlation of the questionnaire among the four languages. The AIBDKQ has an excellent discriminant ability and internal consistency with a strong correlation when compared to the standard CCKNOW questionnaire.

Sections du résumé

BACKGROUND BACKGROUND
Inflammatory bowel disease is an uncommon disease in developing nations whereby patient's knowledge on the disease may be limited. The CCKNOW questionnaire, a widely known questionnaire to assess patient's knowledge on the disease, may be too complex to comprehend for patients in developing countries. The aim of this study is to develop a new tool known as AIBDKQ questionnaire to evaluate the local inflammatory bowel disease patient's knowledge.
METHODS METHODS
This was a prospective study carried out in four phases. In phase 1, three gastroenterologists with expertise in IBD generated a total of 21 questions related to the general knowledge of the disease in the English language. Phase 2 involved content and face validity whereby the questions were further validated by other gastroenterologists. In phase 3, the validated questions were translated into three languages namely Malay, Mandarin and Tamil which are commonly used in Malaysia. In phase 4 (statistical validity), administration of the questionnaires to patients and hospital staff were conducted to assess the construct validity, discriminative ability, predictive validity and reliability of the questionnaires.
RESULTS RESULTS
A total of 21 questions were generated initially. Further evaluation indicated that 20 items had adequate kappa and content validity index for relevance (CVI: 0.714 to 1, Kapp: 0.645 to 1) and clarity (CVI: 0.714 to 1, Kapp: 0.645 to 1). The questionnaires in four languages were administered to 213 patients to assess the construct validity. Six items were removed (three for low communality, one for small loading factors, two for cross loading), resulting in 16 final questions. Assessment with 34 hospital staff involving nurses, doctors and clerks showed significant differences in knowledge between the groups (F = 14.007, p < 0.001) and were able to discriminate doctors from nurses and clerks. Another group of 18 hospital staff administered with AIBDKQ and CCKNOW questionnaires showed a Pearson's correlation coefficient of 0.8 indicating strong correlation and concurrent predictive validity between the two questionnaires. Final assessment with 38 patients for reliability assessment revealed high intraclass correlation of the questionnaire among the four languages.
CONCLUSIONS CONCLUSIONS
The AIBDKQ has an excellent discriminant ability and internal consistency with a strong correlation when compared to the standard CCKNOW questionnaire.

Identifiants

pubmed: 37231353
doi: 10.1186/s12876-023-02817-0
pii: 10.1186/s12876-023-02817-0
pmc: PMC10210279
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

185

Informations de copyright

© 2023. The Author(s).

Références

Singapore Med J. 2010 Jun;51(6):484-9
pubmed: 20658108
Asian Pac J Cancer Prev. 2010;11(3):815-22
pubmed: 21039060
Korean J Intern Med. 2019 Jan;34(1):81-89
pubmed: 29172400
J Crohns Colitis. 2015 May;9(5):404-9
pubmed: 25744112
Psychol Assess. 2012 Jun;24(2):282-92
pubmed: 21966933
Indian J Gastroenterol. 2013 Nov;32(6):369-75
pubmed: 23999682
Am J Gastroenterol. 1999 Dec;94(12):3560-6
pubmed: 10606319
BMC Public Health. 2019 Jun 13;19(Suppl 4):550
pubmed: 31196184
Inflamm Bowel Dis. 2018 Apr 23;24(5):943-952
pubmed: 29506217
BMC Gastroenterol. 2007 Jun 08;7:20
pubmed: 17559670
Public Health Rep. 2009 May-Jun;124(3):471-4
pubmed: 19445426
Int J Colorectal Dis. 2006 Jul;21(5):433-40
pubmed: 16132999
Inflamm Bowel Dis. 2015 Mar;21(3):615-22
pubmed: 25636120
Aliment Pharmacol Ther. 2012 Jul;36(1):57-63
pubmed: 22568682
J Crohns Colitis. 2014 Aug;8(8):796-801
pubmed: 24467964
J Gen Intern Med. 2020 Sep;35(9):2680-2686
pubmed: 32185659
BMC Public Health. 2021 Jun 22;21(1):1186
pubmed: 34158013
World J Gastroenterol. 2015 May 21;21(19):6001-7
pubmed: 26019466
Gastroenterology. 2012 Jan;142(1):46-54.e42; quiz e30
pubmed: 22001864
J Clin Gastroenterol. 2020 Sep;54(8):720-724
pubmed: 31764490

Auteurs

Nik Razima Wan Ibrahim (N)

Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 59100, Malaysia.

Mahmoud Danaee (M)

Department of Social Preventive Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia.

Xin-Hui Khoo (XH)

Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 59100, Malaysia.

Suresh Sithambaram (S)

Manipal Hospitals, Port Klang, Selangor, Malaysia.

Shahreedhan Shahrani (S)

Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 59100, Malaysia.

Alex Hwong-Ruey Leow (A)

Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 59100, Malaysia.

Jo-Ven Chang (JV)

Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 59100, Malaysia.

John Francis Mayberry (J)

Nuffield Hospital, Leicester, UK.

Ida Normiha Hilmi (I)

Division of Gastroenterology and Hepatology, Department of Medicine, Faculty of Medicine, University Malaya, Lembah Pantai, Kuala Lumpur, 59100, Malaysia. ida.hilmi@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH